Skip to main content

and
  1. Article

    Open Access

    Stop** targeted therapy for complete responders in advanced BRAF mutant melanoma

    BRAF inhibitors revolutionised the management of melanoma patients and although resistance occurs, there is a subgroup of patients who maintain durable disease control. For those cases with durable complete re...

    L. Warburton, T. M. Meniawy, L. Calapre, M. Pereira, A. McEvoy in Scientific Reports (2020)